BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17621022)

  • 1. Boron neutron capture therapy for malignant tumors related to meningiomas.
    Miyatake S; Tamura Y; Kawabata S; Iida K; Kuroiwa T; Ono K
    Neurosurgery; 2007 Jul; 61(1):82-90; discussion 90-1. PubMed ID: 17621022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boron neutron capture therapy for recurrent high-grade meningiomas.
    Kawabata S; Hiramatsu R; Kuroiwa T; Ono K; Miyatake S
    J Neurosurg; 2013 Oct; 119(4):837-44. PubMed ID: 23808536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages.
    Miyatake S; Kawabata S; Kajimoto Y; Aoki A; Yokoyama K; Yamada M; Kuroiwa T; Tsuji M; Imahori Y; Kirihata M; Sakurai Y; Masunaga S; Nagata K; Maruhashi A; Ono K
    J Neurosurg; 2005 Dec; 103(6):1000-9. PubMed ID: 16381186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET pharmacokinetic analysis to estimate boron concentration in tumor and brain as a guide to plan BNCT for malignant cerebral glioma.
    Nariai T; Ishiwata K; Kimura Y; Inaji M; Momose T; Yamamoto T; Matsumura A; Ishii K; Ohno K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S348-50. PubMed ID: 19375930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudoprogression in boron neutron capture therapy for malignant gliomas and meningiomas.
    Miyatake S; Kawabata S; Nonoguchi N; Yokoyama K; Kuroiwa T; Matsui H; Ono K
    Neuro Oncol; 2009 Aug; 11(4):430-6. PubMed ID: 19289492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of 4-borono-2-[18F]fluoro-L-phenylalanine in sporadic and neurofibromatosis 2-related schwannoma and meningioma studied with PET.
    Havu-Aurén K; Kiiski J; Lehtiö K; Eskola O; Kulvik M; Vuorinen V; Oikonen V; Vähätalo J; Jääskeläinen J; Minn H
    Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):87-94. PubMed ID: 16896669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning.
    Kabalka GW; Smith GT; Dyke JP; Reid WS; Longford CP; Roberts TG; Reddy NK; Buonocore E; Hübner KF
    J Nucl Med; 1997 Nov; 38(11):1762-7. PubMed ID: 9374349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
    Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
    Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation-induced meningiomas after BNCT in patients with malignant glioma.
    Kageji T; Sogabe S; Mizobichi Y; Nakajima K; Shinji N; Nakagawa Y
    Appl Radiat Isot; 2015 Dec; 106():256-9. PubMed ID: 26122975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BNCT for recurrent intracranial meningeal tumours - case reports.
    Stenstam BH; Pellettieri L; Sorteberg W; Rezaei A; Sköld K
    Acta Neurol Scand; 2007 Apr; 115(4):243-7. PubMed ID: 17376121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of positron emission tomography to develop boron neutron capture therapy treatment plans for metastatic malignant melanoma.
    Kabalka GW; Nichols TL; Smith GT; Miller LF; Khan MK; Busse PM
    J Neurooncol; 2003; 62(1-2):187-95. PubMed ID: 12749713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boron neutron capture therapy for recurrent malignant meningioma. Case report.
    Tamura Y; Miyatake S; Nonoguchi N; Miyata S; Yokoyama K; Doi A; Kuroiwa T; Asada M; Tanabe H; Ono K
    J Neurosurg; 2006 Dec; 105(6):898-903. PubMed ID: 17405262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Boron Neutron Capture Therapy (BNCT) for Recurrent Intracranial Meningioma.
    Lan TL; Lin CF; Lee YY; Lin KH; Chang FC; Lin SC; Lee JC; Chou FI; Peir JJ; Liu HM; Mu PF; Chen YW
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boron neutron capture therapy for malignant brain tumors.
    Miyatake SI; Wanibuchi M; Hu N; Ono K
    J Neurooncol; 2020 Aug; 149(1):1-11. PubMed ID: 32676954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model.
    Wang HE; Liao AH; Deng WP; Chang PF; Chen JC; Chen FD; Liu RS; Lee JS; Hwang JJ
    J Nucl Med; 2004 Feb; 45(2):302-8. PubMed ID: 14960653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Sequential" boron neutron capture therapy (BNCT): a novel approach to BNCT for the treatment of oral cancer in the hamster cheek pouch model.
    Molinari AJ; Pozzi EC; Monti Hughes A; Heber EM; Garabalino MA; Thorp SI; Miller M; Itoiz ME; Aromando RF; Nigg DW; Quintana J; Santa Cruz GA; Trivillin VA; Schwint AE
    Radiat Res; 2011 Apr; 175(4):463-72. PubMed ID: 21294607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation injury of boron neutron capture therapy using mixed epithermal- and thermal neutron beams in patients with malignant glioma.
    Kageji T; Nagahiro S; Mizobuchi Y; Toi H; Nakagawa Y; Kumada H
    Appl Radiat Isot; 2004 Nov; 61(5):1063-7. PubMed ID: 15308193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using salvage Boron Neutron Capture Therapy (BNCT) for recurrent malignant brain tumors in Taiwan.
    Lan TL; Chou FI; Lin KH; Pan PS; Lee JC; Huang WS; Liu YM; Chao Y; Chen YW
    Appl Radiat Isot; 2020 Jun; 160():109105. PubMed ID: 32351215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic assessment of
    Lin KH; Chen YW; Wang LW; Wang YF; Hu LH; Ting CH; Lee TH; Lee JC; Peng NJ
    Quant Imaging Med Surg; 2024 Jun; 14(6):4177-4188. PubMed ID: 38846276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early effect of boron neutron capture therapy mediated by boronophenylalanine (BPA-BNCT) on mast cells in premalignant tissue and tumors of the hamster cheek pouch.
    Aromando RF; Trivillin VA; Heber EM; Pozzi E; Schwint AE; Itoiz ME
    Oral Oncol; 2010 May; 46(5):355-9. PubMed ID: 20308008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.